Prescription drug pricing. Prostate cancer screening. Women's health.
2025 · 2nd Quarter (Apr 1 - June 30)
ASTELLAS PHARMA US, INC.
Filed by TODD STRATEGY GROUP.
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 19, 2025
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- TODD STRATEGY GROUP
- Client
- ASTELLAS PHARMA US, INC.
- Filing UUID
- 0ae39bc3-567b-46f0-aa84-7d5c4db8e077
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Prescription drug pricing. Prostate cancer screening. Women's health.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.